 Patients with ventricular tachycardia of unknown origin and treated with an implantable cardioverter-defibrillator ICD will be asked to participate in the study. For patients with results showing mutations in the calmodulin genes, family members parents, siblings and children will also be asked to participate in the study. For under age patients and relatives who agree to participate, informed consent will also be taken from their custodian. 